[The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes]. 1990

S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
Department of Dermatology, Faculty of Medicine, Toyama Medical and Pharmaceutical University.

Gas chromatography was applied for determination of the amounts of propionic and butyric acids in the medium produced by Propionibacterium acnes. The organism was incubated in Peptone-Yeast extract-Glucose medium containing 0.017 mEq/ml of tributyrin and various amounts of Coptidis Rhizoma at 37 degrees C for 24 to 96 hr. The amount of butyric acid produced by the lipase was reduced parallel with that of propionic acid resulted from the growth of P. acnes in the medium. These facts were also confirmed by counting the cell numbers of P. acnes. Furthermore, any lipase-negative colonies were not observed on the Kishishita's Lipase Medium. These findings indicate that Coptidis Rhizoma inhibits growth of P. acens and anti-lipase activity of the drug against the organism is resulted from the fact.

UI MeSH Term Description Entries
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
August 1998, International journal of antimicrobial agents,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
January 2002, Dermatology (Basel, Switzerland),
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
January 2017, Microbiology and immunology,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
January 2001, Drugs under experimental and clinical research,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
January 2008, Actas dermo-sifiliograficas,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
August 2000, The Journal of dermatology,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
January 1982, Infection and immunity,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
November 2017, International journal of systematic and evolutionary microbiology,
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
August 2018, Molecules (Basel, Switzerland),
S Higaki, and Y Hasegawa, and M Morohashi, and K Sakamoto, and T Yamagishi
July 1988, BMJ (Clinical research ed.),
Copied contents to your clipboard!